CAMBRIDGE, Mass., March 2 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals
Incorporated (Nasdaq: VRTX) will webcast its presentations at the Cowen & Co.
26th Annual Health Care Conference on March 6, 2006 and at the Citigroup 2006
Small & Mid-Cap Conference on March 16, 2006.
Joshua Boger, Ph.D., Chairman, President and Chief Executive Officer of
Vertex, will present at the Cowen & Co. Health Care conference. Vertex's
presentation will be conducted on Monday, March 6, 2006 at 3:10 p.m. EST.
Ian Smith, Executive Vice President and Chief Financial Officer of Vertex,
will present at the Citigroup 2006 Small & Mid-Cap Conference. The
presentation and discussion will be conducted on Thursday, March 16, 2006 at
9:25 a.m. PST (12:25 p.m. EST).
The presentations will be webcast live and may be accessed by visiting the
Vertex website at http://www.vrtx.com. A replay of the webcasts will also be
available on the Company's website for two weeks following the presentations.
To access the webcasts, go to Vertex's website and select the 'Cowen & Co.
26th Annual Health Care Conference' or the 'Citigroup Small and Mid-Cap
Conference' from the 'Events Calendar.' To ensure a timely connection, it is
recommended that users register at least 15 minutes prior to the scheduled
webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small molecule
drugs for serious diseases. The Company's strategy is to commercialize its
products both independently and in collaboration with major pharmaceutical
companies. Vertex's product pipeline is principally focused on viral
diseases, inflammation, autoimmune diseases and cancer. In collaboration with
GlaxoSmithKline, Vertex co-promotes the HIV protease inhibitor, Lexiva.
Lexiva is a registered trademark of the GlaxoSmithKline group of
companies.
Vertex's press releases are available at http://www.vrtx.com.
Vertex Contact:
Lora Pike, Manager, Investor Relations, (617) 444-6755
SOURCE Vertex Pharmaceuticals Incorporated
 back to top
Related links:
http://www.vrtx.com
Company News On-Call:
http://www.prnewswire.com/comp/938395.html
CONTACT:
Lora Pike, Manager, Investor Relations of
Vertex Pharmaceuticals Incorporated, +1-617-444-6755
|
